7月6日，赛默飞世尔盘中下跌3.05%，报509.33美元/股，成交额1.63亿美元。
消息面上，Evercore ISI将赛默飞世尔目标价从575美元下调至570美元，维持跑赢大盘评级。该股当前均值目标价为595美元，评级为超配。值得注意的是，近期多家机构持续下调目标价，此前HSBC曾将评级从买入下调至持有，目标价大幅下调至540美元；Piper Sandler以中性评级首次覆盖，目标价仅510美元，接近当前股价水平。
行业层面，生命科学工具和服务板块整体承压，同业丹纳赫同期下跌3.76%，板块联动效应显著。公司下次财报将于7月23日盘前发布，市场预期EPS为5.71美元。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.